BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
FGF21
,
Metabolism of xenobiotics
,
Arthritis
,
Endothelial cell
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dna topoisomerase ii a
Summary
General Info
Curated Studies
Most Correlated Studies
Retinal pigment epithelium hTERT RPE-1 cells treated with merbarone
Topoisomerase II RNAi knockdown in S2 cells
DNA topoisomerase deficiencies affects on gene expression
Hearts from TOP2B-knockout and wildtype mice after doxorubicin treatment
Human mammary epithelial cells transfected with B-Myb
Explore Curated Studies Results
Literature
Most Relevant Literature
The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform…
Dual functions of the homeoprotein DLX4 in modulating responsiveness of tumor cells to topoisomerase…
The impact of the C-terminal domain on the interaction of human DNA topoisomerase II α and β with DN…
Cadmium is a catalytic inhibitor of DNA topoisomerase II.
DNA topoisomerase II alpha: a favorable prognostic factor in colorectal caner.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast …
Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubic…
DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acu…
Combination Therapy in Cancers With Mutations in DNA Repair Genes
Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ